Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Albany Post.
Press releases published on August 14, 2025

Contact Levi & Korsinsky by October 7, 2025 Deadline to Join Class Action Against CTO Realty Growth, Inc.(CTO)
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 3, 2025 in Tesla, Inc. Lawsuit – TSLA
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

Shareholders of Hims & Hers Health, Inc. Should Contact Levi & Korsinsky Before August 25, 2025 to Discuss Your Rights – HIMS
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

Investors in Neogen Corporation Should Contact Levi & Korsinsky Before September 16, 2025 to Discuss Your Rights – NEOG
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

Altimmune, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – ALT
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

XWELL Reports Second Quarter 2025 Results
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- XWELL, Inc. (Nasdaq: XWEL) ("XWELL" or the "Company"), a leading provider of wellness solutions for people on the go, today announced results for the second quarter ended June 30, 2025. From providing critical …

Sable Offshore Corp. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before September 26, 2025 to Discuss Your Rights – SOC
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

iRobot Corporation Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 5, 2025 to Discuss Your Rights – IRBT
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

Class Action Filed Against Flywire Corporation (FLYW) Seeking Recovery for Investors – Contact Levi & Korsinsky
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

BHVN LAWSUIT ALERT: Levi & Korsinsky Notifies Biohaven Ltd. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

Contact Levi & Korsinsky by August 29, 2025 Deadline to Join Class Action Against Petco Health and Wellness Company, Inc. (WOOF)
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Sarepta Therapeutics, Inc. (SRPT) Shareholders
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

Investors who lost money on Alto Neuroscience, Inc. (ANRO) should contact Levi & Korsinsky about pending Class Action - ANRO
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Levi …

SUNation Energy Reschedules 2025 Second Quarter Financial Results and Conference Call
RONKONKOMA, N.Y., Aug. 14, 2025 (GLOBE NEWSWIRE) -- SUNation Energy, Inc. (Nasdaq: SUNE) (“the Company”), a leading provider of sustainable solar energy and backup power solutions for households, businesses, and municipalities, today announced that it has …

CMMB, with P&G Support, Responds to Deadly Cholera and Hunger Crisis in South Sudan
Juba, South Sudan, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Catholic Medical Mission Board (CMMB) is launching an emergency response in South Sudan as compounding crises threaten thousands of lives in Upper Nile region and Central Equatoria State. The devastating …

Fortress Biotech Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Fortress subsidiary Checkpoint Therapeutics acquired by Sun Pharma; Fortress received ~$28 million at closing and is eligible to receive up to an additional $4.8 million under a contingent value right (CVR), plus a 2.5% royalty on future net sales of …

SL Green Realty Corp. to Present at the BofA Securities 2025 Global Real Estate Conference on September 10, 2025
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- SL Green Realty Corp. (NYSE: SLG), New York City’s largest office landlord, today announced that Matt DiLiberto, Chief Financial Officer, Harrison Sitomer, Chief Investment Officer, and Steven Durels, Executive …

IO Biotech Reports Second Quarter 2025 Financial Results and Provides Business Highlights
Announced clinical improvement in progression free survival observed in pivotal Phase 3 Trial of Cylembio® plus KEYTRUDA® (pembrolizumab) for the treatment of first-line advanced melanoma, but statistical significance narrowly missed; company plans to meet …

AmpliTech Group Advances Strategic Growth Plan with Tier 1 Customer Base Penetration in Multi-Billion Dollar 5G Markets with Record Q2 Revenues
HAUPPAUGE, N.Y., Aug. 14, 2025 (GLOBE NEWSWIRE) -- AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for global communications infrastructure, including 5G/6G ORAN, …

FI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fiserv, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz …